Back close

Oral High Dose Dexamethasone for Pure Red Cell Aplasia Following ABO-Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report

Publication Type : Journal Article

Publisher : Springer Science and Business Media LLC

Source : Indian Journal of Hematology and Blood Transfusion

Url : https://doi.org/10.1007/s12288-013-0276-x

Campus : Faridabad

School : School of Medicine

Year : 2013

Abstract : Management of pure red cell aplasia following major ABO-mismatched hematopoietic stem cell transplantation is a therapeutic challenge. Various therapeutic modalities have been tried with variable responses, and patient remains transfusion dependent for a long time. We report here the use of pulsed oral high dose dexamethasone for pure red cell aplasia following ABO-mismatched allogeneic transplant with complete recovery.

Cite this Research Publication : Sanjeev Kumar Sharma, Suman Kumar, Narendra Agrawal, Pravas Mishra, Tulika Seth, Manoranjan Mahapatra, Oral High Dose Dexamethasone for Pure Red Cell Aplasia Following ABO-Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report, Indian Journal of Hematology and Blood Transfusion, Springer Science and Business Media LLC, 2013, https://doi.org/10.1007/s12288-013-0276-x

Admissions Apply Now